Pharmacokinetic profiles and improvement of resveratrol and derived stilbenes

Aljabali, A.A.A., Bakshi, H.A., Hakkim, F.L., Haggag, Y.A., Al-Batanyeh, K.M., Al Zoubi, M.S., Al-Trad, B., Nasef, M.M., Satija, S., Mehta, M., Pabreja, K., Mishra, V., Khan, M., Abobaker, S., Azzouz, I.M., Dureja, H., Pabari, R.M., Dardouri, A.A.K., Kesharwani, P., Gupta, G., Dhar Shukla, S., Prasher, P., Charbe, N.B., Negi, P., Kapoor, D.N., Chellappan, D.K., Webba da Silva, M., Thompson, P., Dua, K., McCarron, P., and Tambuwala, M.M. (2020). Albumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon Cancer Via Downregulation of Nuclear p65 and HIF-1alpha. Cancers (Basel) 12: 113.

Ates, O., Cayli, S.R., Yucel, N., Altinoz, E., Kocak, A., Durak, M.A., Turkoz, Y., and Yologlu, S. (2007). Central nervous system protection by resveratrol in streptozotocin-induced diabetic rats. J. Clin. NeuroSci. 14: 256–260.

Azzolini, M., La Spina, M., Mattarei, A., Paradisi, C., Zoratti, M., and Biasutto, L. (2014). Pharmacokinetics and tissue distribution of pterostilbene in the rat. Mol. Nutr. Food Res. 58: 2122–2132.

Baek, Y., Jeong, E.W., and Lee, H.G. (2023). Encapsulation of resveratrol within size-controlled nanoliposomes: Impact on solubility, stability, cellular permeability, and oral bioavailability. Colloids Surf. B Biointerfaces 224: 113205.

Bastianetto, S., Ménard, C., and Quirion, R. (2015). Neuroprotective action of resveratrol. Biochim. Biophys. Act. 1852: 1195–1201.

Bonnefont-Rousselot, D. (2016). Resveratrol and cardiovascular diseases. Nutrients 8: 250.

Breuss, J.M., Atanasov, A.G., and Uhrin, P. (2019). Resveratrol and its effects on the vascular system. Int. J. Mol. Sci. 20: 1523.

Cai, T.-T., Ye, X.-L., Li, R.-R., Chen, H., Wang, Y.-Y., Yong, H.-J., Pan, M.-L., Lu, W., Tang, Y., Miao, H., Snijders, A.M., Mao, J.-H., Liu, X.-Y., and Ding, D.-F. (2020). Resveratrol modulates the gut microbiota and inflammation to protect against diabetic nephropathy in mice. Front. Pharmacol. 11: 1249.

Carey, A.N., Fisher, D.R., Rimando, A.M., Gomes, S.M., Bielinski, D.F., and Shukitt-Hale, B. (2013). Stilbenes and anthocyanins reduce stress signaling in BV-2 mouse microglia. J. Agric. Food Chem. 61: 5979–5986.

Chan, C.-M., Chang, H.-H., Wang, V.-C., Huang, C.-L., and Hung, C.-F. (2013). Inhibitory effects of resveratrol on PDGF-BB-induced retinal pigment epithelial cell migration via PDGFRβ, PI3K/Akt and MAPK pathways. PLoS ONE 8: e56819.

Chang, J., Rimando, A., Pallas, M., Camins, A., and Casadesus, G. (2011). Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer’s disease. Neurobiol. Aging. 33(9): 2062–2071.

Chen, G.T., Yang, M., Chen, B.B., Song, Y., Zhang, W., and Zhang, Y. (2016). 2,3,5,4′-tetrahydroxystilbene-2-O-β-d-glucoside exerted protective effects on diabetic nephropathy in mice with hyperglycemia induced by streptozotocin. Food Funct. 7: 4628–36.

Chen, W., Yeo, S., Elhennawy, M.A., and Lin, H.S. (2016). Oxyresveratrol: A bioavailable dietary polyphenol. J. Funct. Foods. 22: 122–131.

Chen, Y., Meng, J., Li, H., Wei, H., Bi, F., Liu, S., Tang, K., Guo, H., and Liu, W. (2019). Resveratrol exhibits an effect on attenuating retina inflammatory condition and damage of diabetic retinopathy via PON1. Exp. Eye Res. 181: 356–66.

Chen, Y., Niu, J., Li, L., Li, Z., Jiang, J., Zhu, M., Dong, T., Zhang, J., Shi, C., and Xu, P. (2020). Polydatin executes anticancer effects against glioblastoma multiforme by inhibiting the EGFR-AKT/ERK1/2/STAT3-SOX2/Snail signaling pathway. Life Sci. 258: 118158.

Chung, I.-M., Subramanian, U., Thirupathi, P., Venkidasamy, B., Samynathan, R., Gangadhar, B.H., Rajakumar, G., and Thiruvengadam, M. (2020). Resveratrol nanoparticles: A promising therapeutic advancement over native resveratrol. Processes 8: 458.

Dai, Y., Lim, J.X., Yeo, S.C.M., Xiang, X., Tan, K.S., Fu, J.H., Huang, L., and Lin, H.S. (2020). Biotransformation of Piceatannol, a dietary resveratrol derivative: Promises to human health. Mol. Nutr. Food Res. 64: e1900905.

Das, S., Lin, H.S., Ho, P.C., and Ng, K.Y. (2008). The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol. Pharm. Res. 25: 2593–2600.

Dellinger, R.W., Garcia, A.M., and Meyskens, F.L. Jr. (2014). Differences in the glucuronidation of resveratrol and pterostilbene: altered enzyme specificity and potential gender differences. Drug Metab Pharmacokinet 29: 112–119.

Deng, L., Li, Y., Zhang, X., Chen, B., Deng, Y., and Li, Y. (2015). UPLC-MS method for quantification of pterostilbene and its application to comparative study of bioavailability and tissue distribution in normal and Lewis lung carcinoma bearing mice. J. Pharm. Biomed. Anal. Links 114: 200–207.

Dong, L.H., Guo, P.P., Yan, W.Y., Zhang, Z.J., and Wang, C.Y. (2014). Comparative study on pharmacokinetics and tissue distribution of cis- and trans-2,3,5,4′-Tetrahydroxystilbene-2-O-beta-D-glucosides in mice. Zhong Yao Cai 37: 1627–1632.

Dong, Y., Wan, G., Yan, P., Qian, C., Li, F., and Peng, G. (2019). Fabrication of resveratrol coated gold nanoparticles and investigation of their effect on diabetic retinopathy in streptozotocin induced diabetic rats. J. Photochem. Photobiol. B. 195: 51–57.

Du, L., Qian, X., Li, Y., Li, Z.-X., He, L.-L., Xu, L., Liu, Y.-Q., Li, C.-C., Ma, P., Shu, F.-L., Lu, Q., and Yin, X.-X. (2021). Sirt1 inhibits renal tubular cell epithelial-mesenchymal transition through YY1 deacetylation in diabetic nephropathy. Acta Pharmacol. Sin. 42: 242–51.

Fan, D., Liu, C., Zhang, Z., Huang, K., Wang, T., Chen, S., and Li, Z. (2022). Progress in the preclinical and clinical study of resveratrol for vascular metabolic disease. Molecules 27: 7524.

Fang, W.-J., Wang, C.-J., He, Y., Zhou, Y.-L., Peng, X.-D., and Liu, S.-K. (2018). Resveratrol alleviates diabetic cardiomyopathy in rats by improving mitochondrial function through PGC-1α deacetylation. Acta Pharmacol. Sin. 39: 59–73.

Giordo, R., Nasrallah, G.K., Posadino, A.M., Galimi, F., Capobianco, G., Eid, A.H., and Pintus, G. (2021). Resveratrol-elicited PKC inhibition counteracts NOX-mediated endothelial to mesenchymal transition in human retinal endothelial cells exposed to high glucose. Antioxidants (Basel) 10: 224.

Gong, W., Li, J., Chen, W., Feng, F., and Deng, Y. (2020). Resveratrol inhibits lipopolysaccharide-induced extracellular matrix accumulation and inflammation in rat glomerular mesangial cells by Sphk1/S1P2/NF-κB pathway. Diabetes Metab. Syndr. Obes. 13: 4495–505.

Guo, R., Liu, W., Liu, B., Zhang, B., Li, W., and Xu, Y. (2015). Sirt1 suppresses cardiomyocyte apoptosis in diabetic cardiomyopathy: An insight into endoplasmic reticulum stress response mechanism. Int. J. Cardiol. 191: 36–45.

Ha, E.S., Choi, D.H., Baek, I.H., Park, H., and Kim, M.S. (2021). Enhanced oral bioavailability of resveratrol by using neutralized Eudragit E solid dispersion prepared via spray drying. Antioxidants (Basel) 10: 90.

Hao, J., Gao, Y., Zhao, J., Zhang, J., Li, Q., Zhao, Z., and Liu, J. (2015). Preparation and optimization of resveratrol nanosuspensions by antisolvent precipitation using Box-Behnken design. AAPS PharmSciTech 16: 118–128.

He, J., Guo, F., Lin, L., Chen, H., Chen, J., Cheng, Y., and Zheng, Z.P. (2018). Investigating the oxyresveratrol β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin complexes: The effects on oxyresveratrol solution, stability, and antibrowning ability on fresh grape juice. Lebensm. Wiss. Technol. 100: 263–270.

He, H., Zhao, Y., Chen, X., Zheng, Y., Wu, X., Wang, R., Li, T., Yu, Q., Jing, J., Ma, L., Ren, W., Han, D., and Wang, G. (2007). Quantitative determination of trans-polydatin, a natural strong anti-oxidative compound, in rat plasma and cellular environment of a human colon adenocarcinoma cell line for pharmacokinetic studies. J. Chromatogr. B. 855: 145–151.

He, T., Xiong, J., Nie, L., Yu, Y., Guan, X., Xu, X., Xiao, T., Yang, K., Liu, L., Zhang, D., Huang, Y., Zhang, J., Wang, J., Sharma, K., and Zhao, J. (2016). Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathway. J. Mol. Med. 94: 1359–71.

Hornedo-Ortega, R., Cerezo, A.B., de Pablos, R.M., Krisa, S., Richard, T., Garcia-Parrilla, M.C., and Troncoso, A.M. (2018). Phenolic Compounds Characteristic of the Mediterranean Diet in Mitigating Microglia-Mediated Neuroinflammation. Front. Cell. Neurosci. 12: 373.

Hou, C.-Y., Tain, Y.-L., Yu, H.-R., and Huang, L.-T. (2019). The effects of resveratrol in the treatment of metabolic syndrome. Int. J. Mol. Sci. 20: 535.

Hu, N., Mei, M., Ruan, J., Wu, W., Wang, Y., and Yan, R. (2014). Regioselective glucuronidation of oxyresveratrol, a natural hydroxystilbene, by human liver and intestinal microsomes and recombinant UGTs. Drug Metab. Pharmacokinet. 29: 229–236.

Huang, B., Xue, L., Wu, Y., and Jiang, Q. (2015). Effect and mechanism of polydatin on diabetic myocardial hypertrophy in mice. Zhongguo Zhong Yao Za Zhi 40: 4256–4261.

Huang, D.D., Shi, G., Jiang, Y., Yao, C., and Zhu, C. (2020). A review on the potential of Resveratrol in prevention and therapy of diabetes and diabetic complications. Biomed. Pharmaco ther. 125: 109767.

Huang, H., Chen, G., Lu, Z., Zhang, J., and Guo, D.-A. (2010). Identification of seven metabolites of oxyresveratrol in rat urine and bile using liquid chromatography/tandem mass spectrometry. Biomed. Chromatogr BMC. 24: 426–432.

Huang, H., Zhang, J., Chen, G., Lu, Z., Wang, X., Sha, N., Shao, B., Li, P., and Guo, D.-A. (2008). High performance liquid chromatographic method for the determination and pharmacokinetic studies of oxyresveratrol and resveratrol in rat plasma after oral administration of Smilax china extract. Biomed. Chromatogr BMC. 22: 421–427.

Huang, Q.-H., Xu, L.-Q., Liu, Y.-H., Wu, J.-Z., Wu, X., Lai, X.-P., Li, Y.-C., Su, Z.-R., Chen, J.-N., and Xie, Y.-L. (2017). Polydatin protects rat liver against ethanol-induced injury: involvement of CYP2E1/ROS/Nrf2 and TLR4/NF-κB p65 pathway. Evid. Based Complement. Altern. Med. 2017: 7953850.

Huang, S.-S., Ding, D.-F., Chen, S., Dong, C.-L., Ye, X.-L., Yuan, Y.-G., Feng, Y.-M., You, N., Xu, J.-R., Miao, H., You, Q., Lu, X., and Lu, Y.-B. (2017). Resveratrol protects podocytes against apoptosis via stimulation of autophagy in a mouse model of diabetic nephropathy. Sci. Rep. 7: 45692.

Huang, X.T., Li, X., Xie, M.L., Huang, Z., Huang, Y.X., Wu, G.X., Peng, Z.R., Sun, Y.N., Ming, Q.L., Liu, Y.X., Chen, J.P., and Xu, S.N. (2019). Resveratrol: Review on its discovery, anti-leukemia effects and pharmacokinetics. Chem. Biol. Interact. 306: 29–38.

Imtiyaz, K., Shafi, M., Fakhri, K.U., Uroog, L., Zeya, B., Anwer, S.T., and Rizvi, M.M.A. (2024). Polydatin: A natural compound with multifaceted anticancer properties. J. Tradit. Complementary. Med.

Inagaki, H., Ito, R., Setoguchi, Y., Oritani, Y., and Ito, T. (2016). Administration of piceatannol complexed with α-cyclodextrin improves its absorption in rats. J. Agric. Food Chem. 64: 3557–3563.

Jia, Y.-N., Peng, Y.-L., Zhao, Y.-P., Cheng, X.-F., Zhou, Y., Chai, C.-L., Zeng, L.-S., Pan, M.-H., and Xu, L. (2019). Comparison of the Hepatoprotective Effects of the Three Main Stilbenes from Mulberry Twigs. J. Agric. Food Chem. 67: 5521–5529.

Johnson, J., Nihal, M., Siddiqui, I.A., Scarlrtt, C.O., Bailey, H.H., Mukhtar, H., and Ahmad, N. (2011). Enhancing the bioavailability of resveratrol by combining it with Piperine. Mol. Nutr. Food Res. 55: 1169–1176.

Joseph, J.A., Fisher, D.R., Cheng, V., Rimando, A.M., and Shukitt-Hale, B. (2008). Cellular and behavioral effects of stilbene resveratrol analogues: implications for reducing the deleterious effects of aging. J. Agric. Food Chem. 56: 10544–10551.

Junsaeng, D., Anukunwithaya, T., Phanit Songvut, P., Sritularak, B., Likhitwitayawuid, K., and Khemawoot, P. (2019). Comparative pharmacokinetics of oxyresveratrol alone and in combination with piperine as a bioenhancer in rats. BMC Complement. Altern. Med. 19: 235.

Kageura, T., Matsuda, H., Morikawa, T., Riguchida, I., Harima, S., Oda, M., and Yoshikawa, M. (2001). Inhibitors from rhubarb on lipopolysaccharide-induced nitric oxide production in macrophages: structural requirements of stilbenes for the activity. Bioorg. Med. Chem. 9: 1887–1893.

Kapetanovic, I.M., Muzzio, M., Huang, Z., Thompson, T.N., and McCormick, D.L. (2011). Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemother. Pharmacol. 68: 593–601.

Kawakami, S., Kinoshita, Y., Maruki-Uchida, H., Yanae, K., Sai, M., and Ito, T. (2014). Piceatannol and its metabolite, isorhapontigenin, induce SIRT1 expression in THP-1 human monocytic cell line. Nutrients 6: 4794–4804.

Kim, Y.H., Kim, Y.S., Roh, G.S., Choi, W.S., and Cho, G.J. (2012). Resveratrol blocks diabetes-induced early vascular lesions and vascular endothelial growth factor induction in mouse retinas. Acta Ophthalmol. 90: e31–7.

Koh, Y.-C., Lien, Y-T., Chou, Y.-T., Ho, C.-T., and Pan, M.-H. (2020). A review: Potential of resveratrol and its analogues to mitigate diseases via gut microbial modulation. J. Food Bioact. 12: 97–105.

Kolodziejczyk-Czepas, J., and Czepas, J. (2019). Rhaponticin as an anti-inflammatory component of rhubarb: a minireview of the current state of the art and prospects for future research. Phytochem Rev. 18: 1375–1386.

Kosuru, R., Kandula, V., Rai, U., Prakash, S., Xia, Z., and Singh, S. (2018). Pterostilbene decreases cardiac oxidative stress and inflammation via activation of AMPK/Nrf2/HO-1 pathway in fructose-fed diabetic rats. Cardiovasc. Drugs. Ther. 32: 147–63.

Kumar, A., Kaundal, R.K., Iyer, S., and Sharma, S.S. (2007). Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy. Life Sci. 80: 1236–44.

Kutil, Z., Kvasnicova, M., Temml, V., Schuster, D., Marsik, P., Cusimamani, E.F., Lou, J.-D., Vanek, T., and Landa, P. (2015). Effect of dietary stilbenes on 5-lipoxygenase and cyclooxygenases activities in vitro. Int. J. Food Prop. 18: 471–1477.

Lai, W.F., Tang, R., and Wong, W.T. (2020). Ionically crosslinked complex gels loaded with oleic acid-containing vesicles for transdermal drug delivery. Pharmaceutics 12: 725.

Li, H., Shi, Y., Wang, X., Li, P., Zhang, S., Wu, T., Yan, Y., Zhan, Y., Ren, Y., Rong, X., Xia, T., Chu, M., and Wu, R. (2019). Piceatannol alleviates inflammation and oxidative stress via modulation of the Nrf2/HO-1 and NF-κB pathways in diabetic cardiomyopathy. Chem. Biol. Interact. 310: 108754.

Li, J., Wang, B., Zhou, G., Yan, X., and Zhang, Y. (2018). Tetrahydroxy stilbene glucoside alleviates high glucose-induced MPC5 podocytes injury through suppression of NLRP3 inflammasome. Am. J. Med. Sci. 355: 588–96.

Li, J., Yu, S., Ying, J., Shi, T., and Wang, P. (2017). Resveratrol prevents ROS-induced apoptosis in high glucose-treated retinal capillary endothelial cells via the activation of AMPK/Sirt1/PGC-1α pathway. Oxi. Med. Cell. Longev. 2017: 7584691.

Li, R.-P., Wang, Z.-Z., Sun, M.-X., Hou, X.-L., Sun, Y., Deng, Z.-F., and Xiao, K. (2012). Polydatin protects learning and memory impairments in a rat model of vascular dementia. Phytomedicine 19: 677–681.

Li, Y., Shin, Y.G., Yu, C., Kosmeder, J.W., Hirschelman, W.H., Pezzuto, J.M., and van Breemen, R.B. (2003). Increasing the throughput and productivity of Caco-2 cell permeability assays using liquid chromatography-mass spectrometry: application to resveratrol absorption and metabolism. Comb. Chem. High Throughput Screen 6: 757–767.

Li, Y.-R., Li, S., and Lin, C.-C. (2018). Effect of resveratrol and pterostilbene on aging and longevity. Biofactors 44: 69–82.

Liang, X., Sun, Y., Zeng, W., Liu, L., Ma, X., Zhao, Y., and Fan, J. (2013). Synthesis and biological evaluation of a folate-targeted rhaponticin conjugate. Bioorg. Med. Chem. 21: 178–185.

Likhitwitayawuid, K. (2021). Oxyresveratrol: Sources, productions, biological activities, pharmacokinetics, and delivery systems. Molecules 26: 4212.

Lin, W.S., Leland, J.V., Ho, C.T., and Pan, M.H. (2020). Occurrence, bioavailability, anti-inflammatory, and anticancer effects of pterostilbene. J. Agric. Food. Chem. 68: 12788–12799.

Liu, K., Liu, J., Xu, A., and Ding, J. (2024). The role of polydatin in inhibiting oxidative stress through SIRT1 activation: A comprehensive review of molecular targets. J. Ethnopharmacol. 331: 118322.

Liu, Q., Chen, J., Qin, Y., Jiang, B., and Zhang, T. (2019). Encapsulation of pterostilbene in nanoemulsions: Influence of lipid composition on physical stability, in vitro digestion, bioaccessibility, and Caco-2 cell monolayer permeability. Food Func. 10: 6604–14.

Liu, S., Yang, Q., Zhang, J., Yang, M., Wang, Y., Sun, T., Ma, C., and El-Aty, A.M.A. (2022). Enhanced stability of stilbene-glycoside-loaded nanoparticles coated with carboxymethyl chitosan and chitosan hydrochloride. Food Chem. 372: 131343.

Liu, Y., Lang, H., Zhou, M., Huang, L., Hui, S., Wang, X., Chen, K., and Mi, M. (2020). The preventive effects of pterostilbene on the exercise intolerance and circadian misalignment of mice subjected to sleep restriction. Mol. Nutr. Food. Res. 64: e1900991.

Long, T., Wang, L., Yang, Y., Yuan, L., Zhao, H., Chang, C.-C., Yang, G., Ho, C.-T., and Li, S. (2019). Protective Effect of Trans-2,3,5,4′-tetrahydroxystilbene 2-O-β-D-glucopyranoside on Liver Fibrosis and Renal Injury Induced by CCl4 via Activating p-ERK1/2 and p-Smad1/2. Food Funct. 10: 5115–5123.

Lv, R., Du, L., Liu, X., Zhou, F., Zhang, Z., and Zhang, L. (2019). Polydatin alleviates traumatic spinal cord injury by reducing microglial inflammation via regulation of iNOS and NLRP3 inflammasome pathway. Int. Immunopharmacol. 70: 28–36.

Lv, R., Du, L., Zhang, L., and Zhang, Z. (2019). Polydatin attenuates spinal cord injury in rats by inhibiting oxidative stress and microglia apoptosis via Nrf2/HO-1 pathway. Life Sci. 217: 119–127.

Malaguarnera, L. (2019). Influence of resveratrol on the immune response. Nutrients 11: 946.

Malik, S.A., Acharya, J.D., Mehendale, N.K., Kamat, S.S., and Ghaskadbi, S.S. (2019). Pterostilbene reverses palmitic acid mediated insulin resistance in HepG2 cells by reducing oxidative stress and triglyceride accumulation. Free Radic. Res. 53: 815–827.

Mamadou, G., Charrueau, C., Dairou, J., Limas-Nzouzi, N., Eto, B., and Ponchel, G. (2017). Increased intestinal permeation and modulation of presystemic metabolism of resveratrol formulated into self-emulsifying drug delivery systems, Int. J. Pharm. 521: 150.

Mohseni, R.Z., ArabSadeghabadi, N., Ziamajidi, R., Abbasalipourkabir, A., and RezaeiFarimani, A. (2019). Oral administration of resveratrol-loaded solid lipid nanoparticle improves insulin resistance through targeting expression of SNARE proteins in adipose and muscle tissue in rats with type 2 diabetes. Nanoscale Res. Lett. 14: 227.

Murias, M., Jäger, W., Handler, N., Erker, T., Horvath, Z., Szekeres, T., Nohl, H., and Gille, L. (2005). Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship. Biochem. Pharmacol. 69: 903–912.

Navarro-Orcajada, S., Vidal-Sánchez, F.J., Conesa, I., Matencio, A., and López-Nicolás, J.M. (2023). Improvement of the physicochemical limitations of rhapontigenin, a cytotoxic analogue of resveratrol against colon cancer. Biomolecules 13(8): 1270.

Ngoc, T.M., Minh, P.T., Hung, T.M., Thuong, P.T., Lee, I., Min, B.S., and Bae, K. (2008). J. Arch. Pharmacal Res. 31: 598–605.

Pandita, D., Kumar, S., Poonia, N., and Lather, V. (2014). Solid lipid nanoparticles enhance oral bioavailability of resveratrol, a natural polyphenol. Food Res. Int. 62: 1165–1174.

Pasinetti, G.M., Wang, J., Ho, L., Zhao, W., and Dubner, L. (2015). Roles of resveratrol and other grape-derived polyphenols in Alzheimer’s disease prevention and treatment. Biochim. Biophys. Acta, Mol. Basis Dis. 1852: 1202–1208.

Pecyna, P., Wargula, J., Murias, M., and Kucinska, M. (2020). More than resveratrol: New insights into stilbene-based compounds. Biomolecules. 10: 1111.

Penalva, R., Esparza, I., Larraneta, E., Gonzalez-Navarro, C.J., Gamazo, C., and Irache, J.M. (2015). Zein-based nanoparticles improve the oral bioavailability of resveratrol and its anti-inflammatory effects in a mouse model of endotoxic shock. J. Agric. Food Chem. 63: 5603–5611.

Peng, J., Lu, C., Luo, Y., Su, X., Li, S., and Ho, C-T. (2024). Hypoglycemic effects and associated mechanisms of resveratrol and related stilbenes in diet. Food Funct. 15: 2381–2405.

Peng, R.M., Lin, G.R., Ting, Y., and Hu, J.Y. (2018). Oral delivery system enhanced the bioavailability of stilbenes: Resveratrol and pterostilbene. BioFactors (Oxford, England) 44: 5–15.

Peritore, A.F., D’Amico, R., Cordaro, M., Siracusa, R., Fusco, R., Gugliandolo, E., Genovese, T., Crupi, R., Di Paola, R., and Cuzzocrea, S. (2021). PEA/Polydatin: Anti-Inflammatory and antioxidant approach to counteract DNBS-induced colitis. Antioxidants 10: 464.

Qiao, Y., Gao, K., Wang, Y., Wang, X., and Cui, B. (2017). Resveratrol ameliorates diabetic nephropathy in rats through negative regulation of the p38 MAPK/TGF-β1 pathway. Exp. Ther. Med. 13: 3223–3230.

Rauf, A., Imran, M., Butt, M.S., Nadeem, M., Peters, D.G., and Mubarak, M.S. (2018). Resveratrol as an anti-cancer agent: A review. Crit. Rev. Food Sci. Nutr. 58: 1428–1447.

Remsberg, C.M., Yáñez, J.A., Ohgami, Y., Vega-Villa, K.R., Rimando, A.M., and Davies, N.M. (2008). Pharmacometrics of pterostilbene: Preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity. Phytother. Res. 22: 169–179.

Rokicki, D., Zdanowski, R., Lewicki, S., Leśniak, M., Suska, M., Wojdat, E., Skopińska-Różewska, E., and Skopiński, P. (2014). Inhibition of proliferation, migration and invasiveness of endothelial murine cells culture induced by resveratrol. Cent. Eur. J. Immunol. 39: 449–454.

Roupe, K.A., Yáñez, J.A., Teng, X.T., and Davies, N.M. (2006). Pharmacokinetics of selected stilbenes: Rhapontigenin, piceatannol and pinosylvin in rats. J. Pharm. Pharmacol. 58: 1443–1450.

Sadi, G., and Konat, D. (2016). Resveratrol regulates oxidative biomarkers and antioxidant enzymes in the brain of streptozotocin-induced diabetic rats. Pharm. Biol. 54: 1156–1163.

Sangsen, Y., Wiwattanawongsa, K., Likhitwitayawuid, K., Sritularak, B., Graidist, P., and Wiwattanapatapee, R. (2016). Influence of surfactants in self-microemulsifying formulations on enhancing oral bioavailability of oxyresveratrol: Studies in Caco-2 cells and in vivo. Int. J. Pharm. 498: 294–303.

Santos, A.C., Pereir, I., Pereira-Silva, M., Ferreira, L., Caldas, M., Collado-González, M., Magalhães, M., Figueiras, A., Ribeiro, A.J., and Veiga, F. (2019). Nanotechnology-based formulations for resveratrol delivery: Effects on resveratrol in vivo bioavailability and bioactivity. Colloids Surf. B Biointerfaces 180: 127–140.

Sergides, C., Chirilă, M., Silvestro, L., Pitta, D., and Pittas, A. (2015). Bioavailability and safety study of resveratrol 500 mg tablets in healthy male and female volunteers. Exp. Ther. Med. 11: 164–170.

Setoguchi, Y., Oritani, Y., Ito, R., Inagaki, H., Maruki-Uchida, H., Ichiyanagi, T., and Ito, T. (2014). Absorption and metabolism of piceatannol in rats. J. Agric. Food. Chem. 62: 2541–2548.

Shah, F.A., Kury, L.A., Li, T., Zeb, A., Koh, P.O., Liu, F., Zhou, Q., Hussain, I., Khan, A.U., Jiang, Y., and Li, S. (2019). Polydatin attenuates neuronal loss via reducing neuroinflammation and oxidative stress in rat MCAO models. Front. Pharmacol. 10: 663.

Shen, H., and Rong, H. (2015). Pterostilbene impact on retinal endothelial cells under high glucose environment. Int. J. Clin. Exp. Pathol. 8: 12589–12594.

Shen, T., Wang, X.N., and Lou, H.X. (2009). Natural stilbenes: an overview. Nat. Prod. Rep. 26: 916–935.

Singh, G., and Pai, R.S. (2015). Trans-resveratrol self-nano-emulsifying drug delivery system (SNEDDS) with enhanced bioavailability potential: optimization, pharmacokinetics and in situ single pass intestinal perfusion (SPIP) studies. Drug Deliv 22: 522–530.

Singh, G., and Pai, R.S. (2016). In vitro and in vivo performance of supersaturable self-nanoe-mulsifying system of trans-resveratrol, Artif. Cells Nanomed. Biotechnol. 44: 510–516.

Soleas, G.J., Angelini, M., Grass, L., Diamandis, E.P., and Goldberg, D.M. (2001). Absorption of trans-resveratrol in rats. Methods. Enzymol. 335: 145–154.

Soo, E., Thakur, S., Qu, Z., Jambhrunkar, S., Parekh, H.S., and Popat, A. (2016). Enhancing delivery and cytotoxicity of resveratrol through a dual nanoencapsulation approach. J. Colloid Interface Sci. 462: 368–374.

Soufi, F.G., Arbabi-Aval, E., Kanavi, M.R., and Ahmadieh, H. (2015). Anti-inflammatory properties of resveratrol in the retinas of type 2 diabetic rats. Clin. Exp. Pharmacol. Physiol. 42: 63–68.

Sun, L.-L., Wang, M., Zhang, H.-J., You, G.-J., Liu, Y.-N., Ren, X.-L., and Deng, Y.-R. (2018). The influence of polysaccharides from Ophiopogon japonicus on 2,3,5,4′-tetrahydroxy-stilbene-2-O-β-D-glucoside about biopharmaceutical properties in vitro and pharmacokinetics in vivo. Int. J. Biol. Macromol. 119: 677–682.

Sun, Y., and Zhao, Y. (2012). Enhanced pharmacokinetics and anti-tumor efficacy of PEGylated liposomal rhaponticin and plasma protein binding ability of rhaponticin. J. Nanosci. Nanotechnol. 12: 7677–7684.

Tian, B., and Liu, J. (2020). Resveratrol: a review of plant sources, synthesis, stability, modification and food application. J. Sci. Food. Agric. 100: 1392–1404.

Torres-Cuevas, I., Millán, I., Asensi, M., Vento, M., Oger, C., Galano, J.M., Durand, T., and Ortega, Á.L. (2021). Analysis of lipid peroxidation by UPLC-MS/MS and retinoprotective effects of the natural polyphenol pterostilbene. Antioxidants 10: 168.

Truong, V.-L., Jun, M., and Jeong, W.-S. (2018). Role of resveratrol in regulation of cellular defense systems against oxidative stress. Biofactors 44: 36–49.

Tzeng, W.S., Teng, W.L., Huang, P.H., Lin, T.C., Yen, F.L., and Shiue, Y.L. (2021). Pterostilbene Nanoparticles Downregulate Hypoxia-Inducible Factors in Hepatoma Cells Under Hypoxic Conditions. Int. J. Nanomedicine 16: 867–879.

Walle, T. (2011). Bioavailability of resveratrol. Ann. N. Y. Acad. Sci. 1215: 9–15.

Walle, T., Hsieh, F., DeLegge, M.H., Oatis, J.E. Jr., and Walle, U.K. (2004). High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos. 32: 1377–1382.

Wang, F.M., Galson, D.L., Roodman, G.D., and Ouyang, H. (2011). Resveratrol triggers the pro-apoptotic endoplasmic reticulum stress response and represses pro-survival XBP1 signaling in human multiple myeloma cells. Exp. Hematol. 39: 999–1006.

Wang, F., Li, R., Zhao, L., Ma, S., and Qin, G. (2020). Resveratrol ameliorates renal damage by inhibiting oxidative stress-mediated apoptosis of podocytes in diabetic nephropathy. Eur. J. Pharmacol. 885: 173387.

Wang, G., Song, X., Zhao, L., Li, Z., and Liu, B. (2018). Resveratrol prevents diabetic cardiomyopathy by increasing Nrf2 expression and transcriptional activity. BioMed Res. Int. 2018: 2150218.

Wang, H.-L., Gao, J.-P., Han, Y.-L., Xu, X., Wu, R., Fai, Y., and Cui, X.-H. (2015). Comparative studies of polydatin and resveratrol on mutual transformation and antioxidative effect in vivo. Phytomedicine. 22: 553–559.

Wang, L., Zhao, H., Wang, L., Tao, Y., Du, G., Guan, W., Liu, J., Brennan, C., Ho, C-T., and Li, S. (2020). Effects of selected resveratrol analogs on activation and polarization of lipopolysaccharid-stimulated BV-2 microglial cells. J. Agric. Food Chem. 68: 3750–3757.

Wang, P., and Sang, S. (2018). Metabolism and pharmacokinetics of resveratrol and pterostilbene. BioFactors. 44: 16–25.

Wang, X., Meng, L., Zhao, L., Wang, Z., Liu, H., Liu, G., and Guan, G. (2017). Resveratrol ameliorates hyperglycemia-induced renal tubular oxidative stress damage via modulating the SIRT1/FOXO3a pathway. Diabetes Res. Clin. Pract. 126: 172–81.

Wen, D., Huang, X., Zhang, M., Zhang, L., Chen, J., Gu, Y., and Hao, C.-M. (2013). Resveratrol attenuates diabetic nephropathy via modulating angiogenesis. PLoS ONE 8: e82336.

Wenzel, E., and Somoza, V. (2005). Metabolism and bioavailability of trans-resveratrol. Mol. Nutr. Food Res. 49: 472–481.

Wu, H., Li, G.N., Xie, J., Li, R., Chen, Q.H., Chen, J.Z., Wei, Z.H., Kang, L.N., and Xu, B. (2016). Resveratrol ameliorates myocardial fibrosis by inhibiting ROS/ERK/TGF-β/periostin pathway in STZ-induced diabetic mice. BMC Cardiovasc. Disord. 16: 5.

Wu, H., Sheng, Z.-Q., Xie, J., Li, R., Chen, L., Li, G.-N., Wang, L., and Xu, B. (2016). Reduced HMGB 1-mediated pathway and oxidative stress in resveratrol-treated diabetic mice: A possible mechanism of cardioprotection of resveratrol in diabetes mellitus. Oxi. Med. Cell. Longev. 2016: 9836860.

Wu, J., Li, M., He, J., Lv, K., Wang, M., Guan, W., Liu, J., Tao, Y., Li, S., Ho, C.-T., and Zhao, H. (2019). Protective effect of pterostilbene on concanavalin A-induced acute liver injury. Food Funct. 10: 7308–7314.

Wu, Z., Huang, A., Yan, J., Liu, B., Liu, Q., Zhang, J., Zhang, X., Ou, C., and Chen, M. (2017). Resveratrol ameliorates cardiac dysfunction by inhibiting apoptosis via the PI3K/Akt/FoxO3a pathway in a rat model of diabetic cardiomyopathy. J. Cardiovasc. Pharmacol. 70: 184–93.

Xian, Y., Gao, Y., Lv, W., Ma, X., Hu, J., Chi, J., Wang, W., and Wang, Y. (2020). Resveratrol prevents diabetic nephropathy by reducing chronic inflammation and improving the blood glucose memory effect in non-obese diabetic mice. Naunyn-Schmiedeberg’s Arch. Pharmacol. 393: 2009–17.

Xie, X., Peng, J., Huang, K., Huang, J., Shen, X., Liu, P., and Huang, H. (2012). Polydatin ameliorates experimental diabetes-induced fibronectin through inhibiting the activation of NF-κB signaling pathway in rat glomerular mesangial cells. Mol. Cell. Endocrinol. 362: 183–193.

Yamamoto, T., Li, Y., Hanafusa, Y., Yeh, Y.-S., Maruki-Uchida, H., Kawakami, S., Sai, M., Goto, T., Ito, T., and Kawada, T. (2017). Piceatannol exhibits anti-inflammatory effects on macrophages interacting with adipocytes. Food Sci. Nutr. 5: 76–85.

Yang, C., Wang, Y., Xie, Y., Liu, G., Lu, Y., Wu, W., and Chen, L. (2019). Oat protein-shellac nanoparticles as a delivery vehicle for resveratrol to improve bioavailability in vitro and in vivo. Nanomedicine (Lond.). 14: 2853–2871.

Yang, G., Zhan, J., Yang, Y., Yuan, L., Wang, P., Ho, C.-T., and Li, S. (2021). Inhibitory effects of oxyresveratrol on ERK and Smad1/2phosphorylation and HSC activation in preventing carbontetrachloride-induced rat liver fibrosis. Food Sci. Hum. Well. 10: 6–12.

Yang, J., Wang, Y., Cai, X., Qu, B., Zhang, Y., Sun, Z., and Yan, J. (2024). Comparative pharmacokinetics and tissue distribution of polydatin, resveratrol, and emodin after oral administration of Huzhang and Huzhang-Guizhi herb-pair extracts to rats. J. Ethnopharmacol. 318: 117010.

Yang, X., Dai, L., Yan, F., Ma, Y., Guo, X., Jenis, J., Wang, Y., Zhang, J., Miao, X., and Shang, X. (2024). The phytochemistry and pharmacology of three Rheum species: A comprehensive review with future perspectives. Phytomedicine. 131: 155772.

Yang, Y., Zhang, G., Li, C., Wang, S., Zhu, M., Wang, J., Yue, H., Ma, X., Zhen, Y., and Shu, X. (2019). Metabolic profile and structure-activity relationship of resveratrol and its analogs in human bladder cancer cells. Cancer Manag. Res. 11: 4631–4642.

Yeo, S.C., Ho, P.C., and Lin, H.S. (2013). Pharmacokinetics of pterostilbene in Sprague-Dawley rats: the impacts of aqueous solubility, fasting, dose escalation, and dosing route on bioavailability. Mol. Nutr. Food Res. 57: 1015–1025.

Zeng, K., Wang, Y., Yang, N., Wang, D., Li, S., Ming, J., Wang, J., Yu, X., Song, Y., Zhou, X., Deng, B., Wu, X., Huang, L., and Yang, Y. (2017). Resveratrol inhibits diabetic-induced Müller cells apoptosis through microRNA-29b/specificity protein 1 pathway. Mol. Neurobiol. 54: 4000–14.

Zeng, K., Yang, N., Wang, D., Li, S., Ming, J., Wang, J., Yu, X., Song, Y., Zhou, X., and Yang, Y. (2016). Resveratrol prevents retinal dysfunction by regulating glutamate transporters, glutamine synthetase expression and activity in diabetic retina. Neurochem. Res. 41: 1050–1064.

Zhan, J., Yang, G., Hu, T., Shen, J., Ho, C.-T., and Li, S. (2021). Pterostilbene is more efficacious than hydroxystilbenes in protecting liver fibrogenesis in a carbon tetracholride-induced rat model. J. Funct. Foods. 84: 104604.

Zhang, J., Dong, X.-J., Ding, M.-R., You, C.-Y., Lin, X., Wang, Y., Wu, M.-J.-Y., Xu, G.-F., and Wang, G.-D. (2020). Resveratrol decreases high glucose-induced apoptosis in renal tubular cells via suppressing endoplasmic reticulum stress.Mol. Med. Rep. 22: 4367–75.

Zhang, K., Chen, J., Raza, F., Zafar, H., Xu, Y., Lui, R., Ullah, K.H., and Zhou, S. (2024). Advancing diabetes treatment: novel formulation of polydatin long-circulating liposomes and their glucose-regulating impact on hyperlipidemia-induced type 2 diabetic mice. Mater. Adv. 5: 6516–6534.

Zhang, W., Yu, H., Lin, Q., Liu, X., Cheng, Y., and Deng, B. (2021). Anti-inflammatory effect of resveratrol attenuates the severity of diabetic neuropathy by activating the Nrf2 pathway. Aging (Albany NY) 13: 10659–10671.

Zhang, Y., Ren, S., Ji, Y., and Liang, Y. (2019). Pterostilbene ameliorates nephropathy injury in streptozotocin-induced diabetic rats. Pharmacology 104: 71–80.

Zhao, Y.Y., Cheng, X.L., Wei, F., Han, X.Q., and Lin, R.C. (2013). Pharmacokinetics, bioavailability, and metabolism of 2,3,5,4′-tetrahydroxystilbene-2-O-β-D-glucoside in rats by ultra-performance liquid chromatography–quadrupole Time-of-Flight mass spectrometry and high-performance liquid chromatography-ultraviolet. J. Liq. Chromatogr. 36: 717–730.

Zhao, Y.Y., Zhang, L., Feng, Y.L., Chen, D.Q., Xi, Z.H., Du, X., Bai, X., and Lin, R.C. (2013). Pharmacokinetics of 2,3,5,4′-tetrahydroxystilbene-2-O-β-D-glucoside in rat using ultra-performance LC-quadrupole TOF-MS. J. Sep. Sci. 36: 863–871.

Zou, Y., Wang, X., Bi, D., Fu, J., Han, J., Guo, Y., Feng, L., and Han, M. (2021). Pterostilbene nanoparticles with small particle size show excellent anti-breast cancer activity in vitro and in vivo. Nanotechnology 32: 325102.

Zhang, Y., Shang, Z., Gao, C., Du, M., Xu, S., Song, H., and Liu, T. (2014). Nanoemulsion for solubilization, stabilization, and in vitro release of pterostilbene for oral delivery. AAPS PharmSciTech. 15: 1000–1008.

Zhao, Y.-Y., Su, Q., Cheng, X.-L., Tan, X.-J., Bai, X., and Lin, R.-C. (2012). Pharmacokinetics, bioavailability and metabolism of rhaponticin in rat plasma by UHPLC-Q-TOF/MS and UHPLC-DAD-MSn. Bioanalysis 4: 713–723.

Zu, Y., Zhang, Y., Wang, W., Zhao, X., Han, X., Wang, K., and Ge, Y. (2014). Preparation and in vitro/in vivo evaluation of resveratrol-loaded carboxymethyl chitosan nano-particles. Drug Deliv. 2014: 1–11.

Zupančič, Š., Lavrič, Z., and Kristl, J. (2015). Stability and solubility of trans-resveratrol are strongly influenced by pH and temperature. Eur. J. Pharm. Biopharm. 93: 196–204.